– Xtampza ® ER Revenues Expected in the Range of $155.0 million to $165.0 million – – Nucynta ® Franchise...
Collegium
– Xtampza® ER Revenues Anticipated in the Variety of $155. million to $165. million – – Nucynta® Franchise Revenues Predicted...
